U.S. President Donald Trump has announced a 100% tariff on pharmaceutical companies that do not manufacture within the United States. The new tariff policy will come into effect from October 1. This move is aimed at boosting domestic production but could significantly impact countries like India, which currently exports around 31% of its pharmaceutical goods to the U.S. The decision is seen as part of Trump’s “America First” policy, targeting foreign dependence in critical sectors like healthcare. Trump stated that the impact of this measure will be “visible very soon.” Analysts warn that this could disrupt global pharma supply chains and hurt India’s export economy.
Breaking News: Trump Imposes 100% Tariff on Foreign Pharma Firms; Major Impact Expected on Indian Exports | ABP NEWS
Previous article![]( "WATCH: Trump Praises Erdogan, Says Turkish Leader “Knows About Rigged Elections Better Than Anybody”")
Next article![]( "Diljit to Nawazuddin: Talent at the International Emmy awards")
